These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 21915819)

  • 1. Metformin after bariatric surgery--an acid problem.
    Aberle J; Reining F; Dannheim V; Flitsch J; Klinge A; Mann O
    Exp Clin Endocrinol Diabetes; 2012 Mar; 120(3):152-3. PubMed ID: 21915819
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term efficacy of metformin therapy in nonobese individuals with type 2 diabetes.
    Ong CR; Molyneaux LM; Constantino MI; Twigg SM; Yue DK
    Diabetes Care; 2006 Nov; 29(11):2361-4. PubMed ID: 17065668
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Medication use after bariatric surgery in a managed care cohort.
    Hodo DM; Waller JL; Martindale RG; Fick DM
    Surg Obes Relat Dis; 2008; 4(5):601-7. PubMed ID: 18539538
    [TBL] [Abstract][Full Text] [Related]  

  • 4. O-glycoside biomarker of apolipoprotein C3: responsiveness to obesity, bariatric surgery, and therapy with metformin, to chronic or severe liver disease and to mortality in severe sepsis and graft vs host disease.
    Harvey SB; Zhang Y; Wilson-Grady J; Monkkonen T; Nelsestuen GL; Kasthuri RS; Verneris MR; Lund TC; Ely EW; Bernard GR; Zeisler H; Homoncik M; Jilma B; Swan T; Kellogg TA
    J Proteome Res; 2009 Feb; 8(2):603-12. PubMed ID: 19055479
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Do risk factors for lactic acidosis influence dosing of metformin?
    Millican S; Cottrell N; Green B
    J Clin Pharm Ther; 2004 Oct; 29(5):449-54. PubMed ID: 15482389
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fifty-two-week efficacy and safety of vildagliptin vs. glimepiride in patients with type 2 diabetes mellitus inadequately controlled on metformin monotherapy.
    Ferrannini E; Fonseca V; Zinman B; Matthews D; Ahrén B; Byiers S; Shao Q; Dejager S
    Diabetes Obes Metab; 2009 Feb; 11(2):157-66. PubMed ID: 19125777
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The effect of metformin on late diabetic complications and cardiovascular events in obese patients with type 2 diabetes].
    Christiansen AL; Madsbad S
    Ugeskr Laeger; 2002 Apr; 164(15):2022-4. PubMed ID: 11984999
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Guideline-conformity of initiation with oral hypoglycemic treatment for patients with newly therapy-dependent type 2 diabetes mellitus in Austria.
    Winkelmayer WC; Stedman MR; Pogantsch M; Wieninger P; Bucsics A; Asslaber M; Bauer R; Burkhardt T; Schautzer A; Brookhart MA;
    Pharmacoepidemiol Drug Saf; 2011 Jan; 20(1):57-65. PubMed ID: 21182153
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Bariatric surgery in children and adolescents].
    Boehm R; Stroh C; Blueher S; Till H; Wolff S; Manger T; Lippert H
    Zentralbl Chir; 2009 Dec; 134(6):532-6. PubMed ID: 20020385
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of a combination of rhGH and metformin on adiponectin levels in patients with metabolic syndrome.
    Herrmann BL; Saller B; Stratmann M; Berg C; Mann K; Janssen OE
    Horm Metab Res; 2005 Jan; 37(1):49-52. PubMed ID: 15702440
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Comparison of two treatment models in type-II diabetic patients with poor metabolic control: Preformed combination of glibenclamide 2,5 mg + metformin 400 mg or mono-therapy with sulfonylurea at maximal doses? An evaluation at six months].
    D'Argenzio R; Cavallo P; Merante D; Morelli A
    Minerva Endocrinol; 1996 Sep; 21(3):101-10. PubMed ID: 9072666
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of short-term treatment with metformin on markers of endothelial function and inflammatory activity in type 2 diabetes mellitus: a randomized, placebo-controlled trial.
    De Jager J; Kooy A; Lehert P; Bets D; Wulffelé MG; Teerlink T; Scheffer PG; Schalkwijk CG; Donker AJ; Stehouwer CD
    J Intern Med; 2005 Jan; 257(1):100-9. PubMed ID: 15606381
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Limitations of metformin use in patients with kidney disease: are they warranted?
    Vasisht KP; Chen SC; Peng Y; Bakris GL
    Diabetes Obes Metab; 2010 Dec; 12(12):1079-83. PubMed ID: 20977579
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Continuing metformin when starting insulin in patients with Type 2 diabetes: a double-blind randomized placebo-controlled trial.
    Douek IF; Allen SE; Ewings P; Gale EA; Bingley PJ;
    Diabet Med; 2005 May; 22(5):634-40. PubMed ID: 15842521
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A dose range finding study of novel oral insulin (IN-105) under fed conditions in type 2 diabetes mellitus subjects.
    Khedkar A; Iyer H; Anand A; Verma M; Krishnamurthy S; Savale S; Atignal A
    Diabetes Obes Metab; 2010 Aug; 12(8):659-64. PubMed ID: 20590742
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Efficacy and safety of glimepiride plus metformin in a single presentation, as combined therapy, in patients with type 2 diabetes mellitus and secondary failure to glibenclamide, as monotherapy].
    González-Ortiz M; Martínez-Abundis E;
    Rev Invest Clin; 2004; 56(3):327-33. PubMed ID: 15612515
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Thus to avoid complications of diabetes. To combine early].
    MMW Fortschr Med; 2001 Nov; 143(44):60. PubMed ID: 11732409
    [No Abstract]   [Full Text] [Related]  

  • 18. The effect of metformin treatment on VEGF and PAI-1 levels in obese type 2 diabetic patients.
    Ersoy C; Kiyici S; Budak F; Oral B; Guclu M; Duran C; Selimoglu H; Erturk E; Tuncel E; Imamoglu S
    Diabetes Res Clin Pract; 2008 Jul; 81(1):56-60. PubMed ID: 18358555
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long term patterns of use after initiation of oral antidiabetic drug therapy.
    Lamberts EJ; Nijpels G; Welschen LM; Hugtenburg JG; Dekker JM; Souverein PC; Bouvy ML
    Pharmacoepidemiol Drug Saf; 2011 Apr; 20(4):351-8. PubMed ID: 21442684
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Appropriate insulin initiation dosage for insulin-naive type 2 diabetes outpatients receiving insulin monotherapy or in combination with metformin and/or pioglitazone.
    Liao L; Yang M; Qiu LL; Mou YR; Zhao JJ; Dong JJ
    Chin Med J (Engl); 2010 Dec; 123(24):3684-8. PubMed ID: 22166651
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.